In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes - PubMed (original) (raw)
. 2007 Dec;30(12):2328-33.
doi: 10.1248/bpb.30.2328.
Affiliations
- PMID: 18057721
- DOI: 10.1248/bpb.30.2328
Free article
In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes
Ryouichi Nonaka et al. Biol Pharm Bull. 2007 Dec.
Free article
Abstract
We constructed a reproducible, simple, and small-scale determination method of the psychoactive drugs that acted directly on the monoamine receptor by measuring the activation of [(35)S]guanosine-5'-O-(3-thio)-triphosphate binding to guanine nucleotide-binding proteins (G proteins). This method can simultaneously measure the effects of three monoamines, namely dopamine (DA), serotonin (5-HT), and norepinephrine (NE), in rat brain membranes using a 96-well microplate. Activation of D(1) and D(2) receptors in striatal membranes by DA as well as 5-HT and NEalpha(2) receptors in cortical membranes could be measured. Of 12 tested phenethylamines, 2,5-dimethoxy-4-chlorophenethylamine (2C-C), 2,5-dimethoxy-4-ethylphenethylamine (2C-E), and 2,5-dimethoxy-4-iodophenethylamine (2C-I) stimulated G protein binding. The other phenethylamines did not affect G protein binding. All 7 tryptamines tested stimulated G protein binding with the following rank order of potency; 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)>5-methoxy-N,N-diallyltryptamine (5-MeO-DALT)>5-methoxy-alpha-methyltryptamine (5-MeO-AMT)>or=5-methoxy-N,N-methylisopropyltryptamine (5-MeO-MIPT)>5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT)>N,N-dipropyltryptamine (DPT)>or=alpha-methyltryptamine (AMT). This assay system was able to designate psychoactive drugs as prohibited substances in accordance with criteria set forth by the Tokyo Metropolitan government.
Similar articles
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
Nagai F, Nonaka R, Satoh Hisashi Kamimura K. Nagai F, et al. Eur J Pharmacol. 2007 Mar 22;559(2-3):132-7. doi: 10.1016/j.ejphar.2006.11.075. Epub 2006 Dec 12. Eur J Pharmacol. 2007. PMID: 17223101 - 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y, Toyoshima R. Odagaki Y, et al. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):335-45. doi: 10.1007/s00210-006-0041-x. Epub 2006 Feb 21. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16491386 - [In-vitro screening of psychoactive drugs to prevent abuses].
Satoh K, Nonaka R. Satoh K, et al. Yakugaku Zasshi. 2008 Dec;128(12):1771-82. doi: 10.1248/yakushi.128.1771. Yakugaku Zasshi. 2008. PMID: 19043296 Review. Japanese. - In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M, Arango V, Hsiung S, Mann JJ, Underwood MD, Liu K, Kassir SA, Ruggiero DA, Tamir H. Adlersberg M, et al. J Neurosci Res. 2000 Sep 15;61(6):674-85. doi: 10.1002/1097-4547(20000915)61:6<674::AID-JNR11>3.0.CO;2-F. J Neurosci Res. 2000. PMID: 10972964 - Clinical toxicology of newer recreational drugs.
Hill SL, Thomas SH. Hill SL, et al. Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Clin Toxicol (Phila). 2011. PMID: 21970769 Review.
Cited by
- New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study.
Altuncı YA, Aydoğdu M, Açıkgöz E, Güven Ü, Düzağaç F, Atasoy A, Dağlıoğlu N, Annette Akgür S. Altuncı YA, et al. Balkan Med J. 2021 Jan;38(1):34-42. doi: 10.4274/balkanmedj.galenos.2020.2019.11.68. Balkan Med J. 2021. PMID: 32936075 Free PMC article. - Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.
Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Cumming P, et al. Molecules. 2021 Apr 22;26(9):2451. doi: 10.3390/molecules26092451. Molecules. 2021. PMID: 33922330 Free PMC article. Review. - Serotonin toxicity of serotonergic psychedelics.
Malcolm B, Thomas K. Malcolm B, et al. Psychopharmacology (Berl). 2022 Jun;239(6):1881-1891. doi: 10.1007/s00213-021-05876-x. Epub 2021 Jul 12. Psychopharmacology (Berl). 2022. PMID: 34251464 Review. - Abuse liability profile of three substituted tryptamines.
Gatch MB, Forster MJ, Janowsky A, Eshleman AJ. Gatch MB, et al. J Pharmacol Exp Ther. 2011 Jul;338(1):280-9. doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7. J Pharmacol Exp Ther. 2011. PMID: 21474568 Free PMC article. - Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.
Shen HW, Jiang XL, Winter JC, Yu AM. Shen HW, et al. Curr Drug Metab. 2010 Oct;11(8):659-66. doi: 10.2174/138920010794233495. Curr Drug Metab. 2010. PMID: 20942780 Free PMC article. Review.